Skip to main content
Official Website of Stem Cell Mexico – Since 2002
Stem Cell Therapy Mexico

Can Stem Cell Therapy cure Multiple Sclerosis (MS) patients?

No. Stem cell therapy does not cure multiple sclerosis (MS), and no current treatment does. MS is a chronic immune condition, and its long-term control relies on disease-modifying therapies prescribed by a neurologist.

Free Consultation
Nervous system location on a neutral human figure

What mesenchymal stem cells (MSCs) can offer is support: they release signals that help regulate the immune system, reduce inflammation and protect nerve tissue, and some patients report improvements in fatigue, mobility, balance or overall well-being. In the MESEMS trial, a phase 2 randomized, double-blind study published in The Lancet Neurology, MSC infusions in people with MS were safe and well tolerated. At Stem Cell Mexico, MS protocols use only allogeneic MSCs from Wharton's jelly of the umbilical cord, usually by intravenous (IV) infusion and, in selected cases after the doctor reviews your medical reports, by an additional intrathecal application. Treatment complements your neurologist's care, results vary between patients, and MS plans typically cost $7,000 to $9,500 USD.

This guide explains why MS is managed rather than cured, the difference between the types of stem cell treatment you may read about, what MSCs can realistically support and how treatment fits with your current care.

Understanding MS

In MS, the immune system attacks myelin, the protective coating around nerve fibers in the brain, spinal cord and optic nerves. This disrupts nerve signals and can cause fatigue, numbness, weakness, vision problems, balance difficulties, bladder symptoms, pain and cognitive changes. Over time, nerve fibers themselves can be damaged.

The main forms are:

  • Relapsing-remitting MS: episodes of new or worsening symptoms followed by partial or complete recovery.
  • Secondary progressive MS: after years of relapses, disability gradually increases.
  • Primary progressive MS: gradual progression from the beginning, without clear relapses.

Why MS is managed rather than cured

MS involves an ongoing immune process, and damage to nerve fibers that has already occurred does not fully reverse. Treatment therefore aims to reduce relapses and new lesions, slow disability, manage symptoms and protect quality of life. Disease-modifying therapies, such as injectable, oral and infusion medications, are the foundation of this strategy.

Two very different types of stem cell treatment

Patients often read about "stem cell therapy for MS" without realizing that two different approaches exist:

Autologous hematopoietic stem cell transplantation (aHSCT)

This intensive procedure uses the patient's own blood stem cells after chemotherapy that resets the immune system. A randomized trial published in JAMA in 2019 found that aHSCT slowed disability progression compared with continued disease-modifying therapy in selected patients with highly active relapsing-remitting MS. It is performed in specialized hospital transplant centers and carries the risks of chemotherapy. The MS International Federation describes it as an option for carefully selected patients. Stem Cell Mexico does not perform aHSCT.

Mesenchymal stem cells (MSCs)

MSC therapy is a lower-intensity approach that does not involve chemotherapy. MSCs act through signals that modulate the immune response and support tissue repair. This is the approach used at Stem Cell Mexico, with cells from Wharton's jelly.

Knowing the difference helps you compare options correctly and ask the right questions about each one.

What MSCs can support

MSCs from Wharton's jelly release anti-inflammatory and neuroprotective factors that may:

  • Help regulate the immune response toward a more balanced state.
  • Reduce inflammation in the nervous system.
  • Protect nerve cells and support myelin repair processes.
  • Support energy and daily function.

Patients sometimes report improvements in fatigue, walking, balance, bladder symptoms or general well-being. The most consistent clinical finding across trials is safety: in the MESEMS trial, infusions were safe and well tolerated, and large meta-analyses of IV MSCs, including a 2026 analysis of umbilical-cord-derived MSCs in Stem Cells Translational Medicine, found temporary fever as the most consistent side effect, without an increase in serious infection, thrombosis, cancer or death.

How treatment fits with your MS care

  • Disease-modifying therapy continues as prescribed by your neurologist. MSC therapy does not replace it.
  • Timing is coordinated with infusions of medications such as anti-CD20 therapies, so the immune system is in a stable phase.
  • Rehabilitation with physical and occupational therapy remains essential.
  • Symptom management, such as treatment for spasticity, bladder symptoms, fatigue and mood, continues.

What our patients usually receive

Based on the treatment plans our team prepares for neurological patients, a typical MS protocol at Stem Cell Mexico includes:

  • Wharton's jelly MSCs by IV infusion, usually between 100 and 200 million cells, depending on body weight and medical review.
  • An additional intrathecal application (similar to an epidural, usually about 60 million cells) in selected cases, only after the doctor reviews your medical reports and confirms you are a candidate.
  • One night at our facilities, sometimes two, with nursing and medical monitoring.
  • Consultation with your doctor and the stem cell specialist, pre-treatment laboratory tests and ground transportation from the San Diego airport area.

MS plans typically cost $7,000 to $9,500 USD, confirmed in your written plan.

Recovery is gradual, and each person responds differently. Some patients begin noticing changes within the first weeks, while others notice them over the following months, which is why our team stays in contact after treatment to follow your progress and decide whether a second application could help.

Heat, fever and MS

Many people with MS notice that heat or fever temporarily worsens symptoms such as fatigue, weakness or blurred vision. This is called pseudo-relapse and usually resolves when the temperature returns to normal. Because a mild fever can follow an MSC infusion, the team monitors your temperature closely, uses paracetamol (acetaminophen) and cooling measures when needed and explains what to expect.

What patients commonly report

When MSC therapy helps, patients usually describe practical changes rather than dramatic ones: more energy across the day, less heaviness in the legs, steadier balance, fewer bathroom urgencies or a better ability to keep up with work and family. Some notice one change, such as less fatigue, before others. Others notice little difference, which is why measuring walking, fatigue and daily function before and after treatment matters more than impressions.

Preparing for treatment with MS

  • Send your records: neurology notes, recent MRI reports, your current disease-modifying therapy and the date of your last relapse.
  • Coordinate timing with your neurologist, especially if you receive infusion therapies.
  • Continue your medications on schedule, including those for spasticity, bladder symptoms and pain, unless the doctor indicates otherwise.
  • Pause anti-inflammatory painkillers, alcohol and certain supplements for the period the doctor indicates.
  • Plan rest before and after travel, since fatigue is common in MS.

Traveling with MS

Long trips can be tiring, and heat can temporarily worsen symptoms. Our driver meets you in the San Diego airport area, so you avoid driving and parking. Bring cooling items such as a fan or cooling vest in warm months, keep water at hand, plan restroom stops and travel with a companion if you use a walking aid or tire easily. Wheelchair assistance at the airport can be requested in advance.

How to measure what changes

  • Walking: timed 25-foot walk or six-minute walk.
  • Fatigue: a validated fatigue scale.
  • Disability: the Expanded Disability Status Scale (EDSS), recorded by your neurologist.
  • Daily function: bladder symptoms, sleep and activities you can do.
  • MRI: routine monitoring as scheduled by your neurologist.

Recording these before treatment and at three and six months shows what changed.

Lifestyle measures that support MS care

Several everyday measures support people living with MS and complement any treatment: regular exercise adapted to your abilities, which improves strength, balance and fatigue; not smoking, since smoking is linked to faster progression; adequate vitamin D, as checked by your doctor; good sleep; and management of stress and mood. These measures are within your control and add to the benefit of both medical treatment and regenerative care.

Who may be a candidate

  • Confirmed MS diagnosis, with neurology records and recent MRI reports.
  • Stable disease, without a relapse in the recent weeks.
  • Continued care with a neurologist.
  • No active infection and no cancer within the past five years.

Warning signs when comparing clinics

Be cautious if a clinic promises to cure MS, suggests stopping disease-modifying therapy, confuses MSC therapy with aHSCT or says the treatment is risk-free.

Questions to ask during your evaluation

  • How will treatment be coordinated with my disease-modifying therapy?
  • Am I a candidate for IV only, or also for an intrathecal application?
  • What changes could be realistic in my type of MS?
  • How will we measure results?

Bottom line

Stem cell therapy does not cure multiple sclerosis, but Wharton's jelly MSCs can support immune balance, reduce inflammation and protect nerve tissue, with a favorable safety record, and some patients report better energy, mobility or well-being. At Stem Cell Mexico, treatment complements your neurologist's care, and results vary between patients. A medical evaluation can help determine whether this type of regenerative treatment is appropriate for your type of MS, goals and medical history.

References

  1. MS International Federation (MSIF): Stem cell therapy for MS (opens in a new tab)
  2. Uccelli A et al. Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial. The Lancet Neurology, 2021 (opens in a new tab)
  3. Burt RK et al. Effect of nonmyeloablative hematopoietic stem cell transplantation vs continued disease-modifying therapy on disease progression in patients with relapsing-remitting multiple sclerosis: a randomized clinical trial. JAMA, 2019 (opens in a new tab)
  4. Hum C et al. Safety of intravascular administration of umbilical-cord-derived mesenchymal stromal cells: an updated systematic review and meta-analysis. Stem Cells Translational Medicine, 2026 (opens in a new tab)

Request your medical evaluation

A clearer path starts here.

Tell us a little about yourself. We’ll help you understand the next step.

Vania, patient coordinator at Stem Cell Mexico

Vania, our patient coordinator

Your questions. Your travel plans.
A real person to help.

Talk to Vania on WhatsApp (opens in a new tab)

What happens next?

  1. Your advisor contacts you.
  2. We explain the medical review.
  3. You explore your options.

Call +1 800 646 0290

Let’s begin with you.

Your inquiry starts a conversation. Treatment requires medical evaluation.

Vania · Patient Advisor

Start my free evaluation
Free Consultation